Word

INNOVENT

Status

Registered

Status Code

700

Status Date

Tuesday, January 5, 2021

Serial Number

88177424

Registration Number

6236173

Registration Date

Tuesday, January 5, 2021

Mark Type

3000

Filing Date

Thursday, November 1, 2018

Published for Opposition

Tuesday, October 20, 2020

Trademark Owner History

Innovent Biologics (Suzhou) Co., Ltd. - Original Registrant

Classifications

5 Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes

Color is not claimed as a feature of the mark.
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "SHENGWUZHIYAO"
The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT".
The non-Latin characters in the mark transliterate to "XIN DA SHENG WU ZHI YAO" and this means "integrity", "action", "bio-pharmaceuticals" in English.

Trademark Events

Jan 5, 2021

Registered-Principal Register

Oct 20, 2020

Official Gazette Publication Confirmation E-Mailed

Oct 20, 2020

Published For Opposition

Sep 30, 2020

Notification Of Notice Of Publication E-Mailed

Sep 17, 2020

1(B) Basis Deleted; New Basis Requested

Sep 17, 2020

Notice Of Allowance Cancelled

Sep 11, 2020

Attorney Review/Decision On Amendment Required

Sep 11, 2020

Petition To Director - Change Basis - Granted

Sep 9, 2020

Assigned To Petition Staff

Jul 24, 2020

Teas Petition To Amend Basis Received

Jun 16, 2020

Noa E-Mailed - Sou Required From Applicant

Apr 21, 2020

Official Gazette Publication Confirmation E-Mailed

Apr 21, 2020

Published For Opposition

Apr 1, 2020

Notification Of Notice Of Publication E-Mailed

Mar 19, 2020

Approved For Pub - Principal Register

Mar 13, 2020

Teas/Email Correspondence Entered

Mar 12, 2020

Correspondence Received In Law Office

Mar 12, 2020

Teas Request For Reconsideration Received

Feb 26, 2020

Notification Of Final Refusal Emailed

Feb 26, 2020

Final Refusal E-Mailed

Feb 26, 2020

Final Refusal Written

Aug 24, 2019

Teas/Email Correspondence Entered

Aug 23, 2019

Correspondence Received In Law Office

Aug 23, 2019

Teas Response To Office Action Received

Mar 11, 2019

Notification Of Non-Final Action E-Mailed

Mar 11, 2019

Non-Final Action E-Mailed

Mar 11, 2019

Non-Final Action Written

Feb 7, 2019

Assigned To Examiner

Nov 17, 2018

Notice Of Design Search Code E-Mailed

Nov 16, 2018

New Application Office Supplied Data Entered In Tram

Nov 5, 2018

New Application Entered In Tram